PR Newswire
SHERIDAN, Wyo., May 14, 2026
SHERIDAN, Wyo., May 14, 2026 /PRNewswire/ — The global hematology diagnostics market is projected to grow from USD 6.1 billion in 2025 to USD 7.6 billion by 2030, registering a CAGR of 6.4% during the forecast period (2026-2030), according to a new study by Wissen Research.
https://mma.prnewswire.com/media/2971885/5971203/Wissen_Research_Logo.jpg
The growing number of cases of blood diseases, increasing demand for disease diagnosis in the early stages, and growing use of automated diagnostic tools have been contributing towards the growth of the haematology diagnostics industry. The healthcare organizations and the diagnostic centers are adopting sophisticated haematology analyzers, flow cytometers, and molecular diagnostic tools to improve the accuracy of testing and efficiency of disease monitoring processes.
Request a Customized Version of This Report Based on Your Business Requirements:
https://www.wissenresearch.com/ask-for-customization/ Technology Advancements Reshaping the Hematology Diagnostics Market
Advances in automation, digital imaging, flow cytometry, and molecular diagnostics technology are revolutionizing the haematology diagnostics industry. With advancements in technology, contemporary haematology analyzers are now able to perform complete blood counts (CBC), white blood cell differential, and other specialized disease diagnoses faster and more accurately without much human intervention. Artificial intelligence and analytics are playing critical roles in improving the detection of abnormal cells, workflow, and efficiency in laboratories.
Rising cases of anaemia, leukaemia, lymphoma, and infections have prompted health facilities to purchase advanced haematology testing equipment to detect these diseases early and accurately. Besides, advances in technology have led to the adoption of high throughput analyzers, point of care testing, and automation in labs, hence speeding up clinical decisions. Additionally, regulatory push towards standardized diagnostics and investment in precision medicines is spurring innovations in the haematology diagnostics industry.
Key Market Drivers for the Hematology Diagnostics Market:
- Growing incidences of blood diseases such as anaemia, leukaemia, lymphoma, and haemophilia are creating a need for tests based on haematology.
- The increasing use of automated haematology analyzers is contributing to improved accuracy, increased efficiency, and quicker tests.
- Growing need for early detection and regular blood tests is helping to expand the market in hospitals and diagnostic centers.
- Development in flow cytometry, molecular diagnostics, and artificial intelligence-based laboratory technologies is helping to improve disease detection.
- Aging population and growing incidences of chronic diseases are leading to a greater number of haematology diagnostics worldwide.
- Increased healthcare facilities and investment in laboratory automation is driving the adoption of advanced haematology diagnostics technologies.
Market Challenges for the Hematology Diagnostics Industry
- Cost issues associated with expensive technology and the automation of laboratories still constitute a barrier to market growth. The use of automated analyzers, flow cytometers, and molecular diagnostics is rather costly due to high capital expenditure and costs of maintenance, thus hindering the use of such equipment by small and medium laboratories.
- A lack of trained personnel is another obstacle for the growth of the market for advanced haematology diagnostics, especially in underdeveloped countries that have fewer resources to train competent staff.
- Data management and standardization can hinder further market development as different testing techniques, quality control methods, and laboratory management systems impact data collection and analysis.
- Finally, reimbursement and compliance-related obstacles may prevent more widespread use of advanced diagnostics. Inadequate payment systems and complicated regulatory policies still pose certain problems to vendors of innovative technologies.
Recent Strategic Developments in the Hematology Diagnostics Market
The deals being struck across the industry tell a clear story — companies are doubling down on enhanced automated analyzers, sophisticated flow cytometry, and refined optical and impedance detection methods, increasingly through partnerships rather than solo efforts.
In June 2025, Sysmex Corporation (Japan) received Health Canada licensing for its new CN-3000™ and CN-6000™ Automated Blood Coagulation Analyzers. These high-throughput, fully automated systems are designed to offer smart workflow features, a small footprint, and expandability to meet various laboratory needs. Sysmex highlights their ability to improve efficiency, accuracy, and patient care, particularly addressing workforce challenges. This development expands Sysmex’s presence in the haemostasis testing segment of the haematology market in Canada.
In May 2025, Shenzhen Dymind Biotechnology Co., Ltd. (China) launched its DH-800 Haematology Analyzer and CA1200 Coagulation Analyzer during an event in Lima, Peru. The launch, held at the Westin Hotel, attracted over 120 key stakeholders, exceeding initial expectations. This marks Dymind’s effort to advance diagnostics and build partnerships within the Peruvian healthcare market.
In April 2025, Sysmex Corporation (Japan) initiated full-scale operations at its new manufacturing base in India, capable of producing both diagnostic reagents and instruments. The company has begun manufacturing its XQ-320 Automated Haematology Analyzer in India to align with the local «Make in India» policy, targeting small and medium-sized medical institutions.
Key Insights from Hematology Diagnostics Market Analysis
- The growing incidence of blood disorders, anaemia, leukaemia, and infectious diseases is driving the global market for haematology diagnostic tests.
- The automation process in haematology analyzers is leading to higher efficiency in laboratories along with reduced turnaround time and increased accuracy.
- Artificial intelligence and digital data management technology is contributing to faster interpretation of test results and efficient workflow process.
- Five and six part differential haematology analyzers are seeing a rise in adoption due to their capability to conduct extensive blood cell examination.
- Various government policies promoting early disease diagnosis and improved diagnostics facilities are boosting the growth of the market in developing countries.
- The Asia-Pacific region is poised to show considerable growth driven by better healthcare infrastructure, high patient base, and investments in laboratories.
Key Players in the Hematology Diagnostics Market
Leading companies in the hematology diagnostics market are focusing on product innovation, strategic collaborations, and expanding health-focused capabilities to strengthen their competitive position.
Company
Key Focus Area
SYSMEX CORPORATION (JAPAN) Automated haematology analyzers and clinical laboratory
diagnostics
SIEMENS HEALTHINEERS (GERMANY) Integrated haematology systems and laboratory
automation
HORIBA, LTD. (JAPAN) Haematology analyzers and blood cell analysis solutions
DANAHER CORPORATION (US) Clinical diagnostics and haematology workflow
technologies
ABBOTT LABORATORIES (US) Diagnostic instruments and point-of-care haematology
testing
BIO-RAD LABORATORIES INC. (US) Quality controls and haematology diagnostic systems
NIHON KOHDEN CORPORATION (JAPAN) Haematology analyzers and laboratory diagnostic
equipment
BOULE DIAGNOSTICS AB (SWEDEN)
Compact haematology analyzers and consumables
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CHINA) Automated blood analysis and haematology diagnostics
F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND) Integrated diagnostics and digital laboratory solutions
EKF DIAGNOSTICS HOLDING PLC (UK) Point-of-care haematology and haemoglobin testing
DREW SCIENTIFIC (US) Haematology instrumentation and laboratory analyzers
DIATRON (HUNGARY)
Haematology analyzers and reagent development
Regional Analysis and Growth Opportunities in the Hematology Diagnostics Market
The North American region plays a dominant role in the hematology diagnostics market due to its advanced health infrastructure, widespread use of automated diagnostic tools, and high incidences of various blood-related diseases. Presence of leading diagnostic companies and increased automation trends among laboratory services drive regional market growth.
It is estimated that the Asia-Pacific region will witness significant growth in the future due to improved accessibility to healthcare facilities, increase in population size, and investment in laboratories in countries like China, India, and Japan. Growing awareness about early detection of disease conditions drives regional demand.
Europe is expected to register continuous growth due to established clinical laboratory services, reimbursement benefits for patients and healthcare providers, and increased use of haematology analyzers. In addition, Latin America and the Middle East & Africa are emerging regions owing to the development of their diagnostics sector.
Product & End Users Insights
Complete Blood Count (CBC) / Differential remained the leading core test type in the haematology diagnostics market in 2025 due to its widespread use in routine health screening, infection detection, anaemia diagnosis, and monitoring of hematologic disorders. CBC testing is among the most frequently performed laboratory tests globally, supported by growing adoption of automated haematology analyzers capable of delivering rapid and accurate multi-parameter blood analysis. Increasing prevalence of blood disorders, infectious diseases, and chronic conditions continues to sustain demand for CBC and differential testing across hospitals and diagnostic laboratories.
Disease diagnosis accounted for the largest application share in the hematology diagnostics market in 2025, driven by rising demand for early and accurate detection of anaemia, leukaemia, lymphoma, infections, and other blood-related disorders. Haematology diagnostics play a critical role in clinical decision-making by supporting disease identification, treatment monitoring, and patient management. Growing healthcare awareness, expanding diagnostic testing volumes, and increasing use of advanced automated analyzers are further supporting the dominance of diagnostic applications in the market.
To purchase the complete Hematology Diagnostics Market report and access detailed forecasts, competitive insights, and growth opportunities, visit: https://www.wissenresearch.com/Pricing/ Market Segmentation Snapshot
The global haematology diagnostics market is segmented across product, core tests, application, end users and regions:
• By Product Type:
- Instruments
- Reagents & Consumables
- Software & Services
• By Core Tests:
- Complete Blood Count (CBC) / Differential
- Coagulation Testing
- Flow Cytometry Testing (Hematology)
- Manual Microscopic Review
• By Application:
- Disease Diagnosis
- Therapeutic Monitoring
- General Health Screening & Monitoring
By End User Industries:
- Hospitals
- Diagnostic Laboratories
- Physician Offices & Clinics
- Home Healthcare & Self-Monitoring
- Academic & Research Institutions
• By Region:
- North America
- Europe
- Asia-Pacific
- Rest of the World
Advancements in automated haematology analyzers, flow cytometry, digital imaging, and AI-assisted diagnostics are significantly improving the speed, accuracy, and efficiency of blood analysis across clinical laboratories. Increasing integration of high-throughput systems, connectivity solutions, and advanced data analytics is enabling faster disease detection and streamlined laboratory workflows. For stakeholders in the haematology diagnostics market, continued opportunities lie in product innovation, expansion of point-of-care haematology testing, strategic collaborations with healthcare providers, and growing adoption of advanced diagnostic technologies in emerging healthcare markets.
Expert Profile | Mayur Jain, Wissen Research
Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry.
Email: [email protected]LinkedIn: https://www.linkedin.com/in/mayur-jain-0190542a/
About Wissen Research
Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets
Company Contact
:
Wissen Research LLC,Gould St, Ste R,Sheridan, WY 82801,Phone: (+1) 510 240 9853Email: [email protected] Website: https://www.wissenresearch.com/ Blog: https://www.wissenresearch.com/insights/ LinkedIn: https://www.linkedin.com/company/wissen-research
Logo – https://mma.prnewswire.com/media/2971885/5971203/Wissen_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/hematology-diagnostics-market-expected-to-reach-us-7-6-billion-by-2030–growing-at-6-4-cagr-wissen-research-302772696.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…